587 related articles for article (PubMed ID: 28536926)
1. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Gut Microbiota in Patients with Parkinson's Disease.
Petrov VA; Saltykova IV; Zhukova IA; Alifirova VM; Zhukova NG; Dorofeeva YB; Tyakht AV; Kovarsky BA; Alekseev DG; Kostryukova ES; Mironova YS; Izhboldina OP; Nikitina MA; Perevozchikova TV; Fait EA; Babenko VV; Vakhitova MT; Govorun VM; Sazonov AE
Bull Exp Biol Med; 2017 Apr; 162(6):734-737. PubMed ID: 28429209
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
4. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
5. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
10. Gut bacterial profiles in Parkinson's disease: A systematic review.
Li Z; Liang H; Hu Y; Lu L; Zheng C; Fan Y; Wu B; Zou T; Luo X; Zhang X; Zeng Y; Liu Z; Zhou Z; Yue Z; Ren Y; Li Z; Su Q; Xu P
CNS Neurosci Ther; 2023 Jan; 29(1):140-157. PubMed ID: 36284437
[TBL] [Abstract][Full Text] [Related]
11. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
12. Colonic bacterial composition in Parkinson's disease.
Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
[TBL] [Abstract][Full Text] [Related]
13. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
14. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.
Hasegawa S; Goto S; Tsuji H; Okuno T; Asahara T; Nomoto K; Shibata A; Fujisawa Y; Minato T; Okamoto A; Ohno K; Hirayama M
PLoS One; 2015; 10(11):e0142164. PubMed ID: 26539989
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
18. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
20. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]